Cognoptix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2001-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cognoptix.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations
Phase 1
- Conditions
- Mild Cognitive ImpairmentAlzheimer's Disease
- Interventions
- Device: Sapphire IIDrug: Aftobetin-HClRadiation: Positron Emission Tomography
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Cognoptix, Inc.
- Target Recruit Count
- 105
- Registration Number
- NCT02928211
- Locations
- 🇺🇸
Neurology Research Institute, West Palm Beach, Florida, United States
News
No news found